London Daily

Focus on the big picture.
Saturday, May 31, 2025

Oxford research suggests risk of rare blood clotting HIGHER for Covid-19 than for VACCINES

Oxford research suggests risk of rare blood clotting HIGHER for Covid-19 than for VACCINES

Researchers at the University of Oxford say Covid-19 leads to a risk of rare blood clots that's several-times higher than that of current vaccines, amid concerns that the jabs may be to blame for the potentially deadly condition.
The report released on Thursday says the risk of the rare condition known as cerebral venous thrombosis (CVT) following Covid-19 infection is “around 100 times greater than normal” and “several times higher” than it is post-vaccination or after flu.

Researchers looked at health records of 500,000 Covid-19 patients to estimate the absolute incidence of CVT in the two weeks following Covid-19 diagnosis, flu, or vaccination against coronavirus. They found that clotting is around eight times more likely to occur after contracting Covid-19 than after immunization with the AZ-Oxford Covid-19 vaccine. Compared to the vaccines made by Pfizer or Moderna, the risk of a CVT from Covid-19 is about 10 times greater.

The researchers, however, call for a cautious interpretation of the comparisons since data is still coming in.

“There are concerns about possible associations between vaccines, and CVT, causing governments and regulators to restrict the use of certain vaccines. Yet, one key question remained unknown: ‘What is the risk of CVT following a diagnosis of Covid-19?’” says Professor of Psychiatry and Head of the Translational Neurobiology Group at the University of Oxford Paul Harrison.

Some countries have restricted the use of the Oxford-AstraZeneca vaccine – which was renamed Vaxzevria – to certain age groups after the European Medicines Agency confirmed the vaccine’s possible links to cases of blood clotting, several of which were fatal. Denmark halted the use of the jab altogether.

Meanwhile, another EMA-approved vaccine, Johnson & Johnson's, is being investigated in the US and Europe following cases of blood clotting and at least one death.

Both vaccines are based on a similar method, known as adenoviral vectors. Regulators and researchers are working to find out whether the incidences of blood clotting are caused by an immune response to the adenovirus vaccines
Newsletter

Related Articles

0:00
0:00
Close
Satirical Sketch Sparks Political Spouse Feud in South Korea
Indonesia Quarry Collapse Leaves Multiple Dead and Missing
South Korean Election Video Pulled Amid Misogyny Outcry
Asian Economies Shift Away from US Dollar Amid Trade Tensions
Netflix Investigates Allegations of On-Set Mistreatment in K-Drama Production
US Defence Chief Reaffirms Strong Ties with Singapore Amid Regional Tensions
Vietnam Faces Strategic Dilemma Over China's Mekong River Projects
Malaysia's First AI Preacher Sparks Debate on Islamic Principles
White House Press Secretary Criticizes Harvard Funding, Advocates for Vocational Training
France to Implement Nationwide Smoking Ban in Outdoor Spaces Frequented by Children
Meta and Anduril Collaborate on AI-Driven Military Augmented Reality Systems
Russia's Fossil Fuel Revenues Approach €900 Billion Since Ukraine Invasion
U.S. Justice Department Reduces American Bar Association's Role in Judicial Nominations
U.S. Department of Energy Unveils 'Doudna' Supercomputer to Advance AI Research
U.S. SEC Dismisses Lawsuit Against Binance Amid Regulatory Shift
Alcohol Industry Faces Increased Scrutiny Amid Health Concerns
Italy Faces Population Decline Amid Youth Emigration
U.S. Goods Imports Plunge Nearly 20% Amid Tariff Disruptions
OpenAI Faces Competition from Cheaper AI Rivals
Foreign Tax Provision in U.S. Budget Bill Alarms Investors
Trump Accuses China of Violating Trade Agreement
Gerry Adams Wins Libel Case Against BBC
Russia Accuses Serbia of Supplying Arms to Ukraine
EU Central Bank Pushes to Replace US Dollar with Euro as World’s Main Currency
Chinese Woman Dies After Being Forced to Visit Bank Despite Critical Illness
President Trump Grants Full Pardons to Reality TV Stars Todd and Julie Chrisley
Texas Enacts App Store Accountability Act Mandating Age Verification
U.S. Health Secretary Ends Select COVID-19 Vaccine Recommendations
Vatican Calls for Sustainable Tourism in 2025 Message
Trump Warns Putin Is 'Playing with Fire' Amid Escalating Ukraine Conflict
India and Pakistan Engage Trump-Linked Lobbyists to Influence U.S. Policy
U.S. Halts New Student Visa Interviews Amid Enhanced Security Measures
Trump Administration Cancels $100 Million in Federal Contracts with Harvard
SpaceX Starship Test Flight Ends in Failure, Mars Mission Timeline Uncertain
King Charles Affirms Canadian Sovereignty Amid U.S. Statehood Pressure
Trump Threatens 25% Tariff on iPhones Amid Dispute with Apple CEO
Putin's Helicopter Reportedly Targeted by Ukrainian Drones
Liverpool Car Ramming Incident Leaves Multiple Injured
Australia Faces Immigration Debate Following Labor Party Victory
Iranian Revolutionary Guard Founder Warns Against Trusting Regime in Nuclear Talks
Macron Dismisses Viral Video of Wife's Gesture as Playful Banter
Cleveland Clinic Study Questions Effectiveness of Recent Flu Vaccine
Netanyahu Accuses Starmer of Siding with Hamas
Junior Doctors Threaten Strike Over 4% Pay Offer
Labour MPs Urge Chancellor to Tax Wealthy Over Cutting Welfare
Publication of UK Child Poverty Strategy Delayed Until Autumn
France Detains UK Fishing Vessel Amid Post-Brexit Tensions
Calls Grow to Resume Syrian Asylum Claims in UK
Nigel Farage Pledges to Reinstate Winter Fuel Payments
Boris and Carrie Johnson Welcome Daughter Poppy
×